Cargando…

Bilateral subconjunctival hemorrhage secondary to abciximab use: case report

CONTEXT: There are no reports on cases of subconjunctival hemorrhage due to use of glycoprotein IIb/IIIa inhibitors. In this report, we present the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab. CASE REPORT: A 40-year-old male patient underwent coronary angiog...

Descripción completa

Detalles Bibliográficos
Autores principales: Kul, Selim, Sayın, Muhammet Raşit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721233/
https://www.ncbi.nlm.nih.gov/pubmed/29267537
http://dx.doi.org/10.1590/1516-3180.2017.0182150717
_version_ 1784843728535420928
author Kul, Selim
Sayın, Muhammet Raşit
author_facet Kul, Selim
Sayın, Muhammet Raşit
author_sort Kul, Selim
collection PubMed
description CONTEXT: There are no reports on cases of subconjunctival hemorrhage due to use of glycoprotein IIb/IIIa inhibitors. In this report, we present the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab. CASE REPORT: A 40-year-old male patient underwent coronary angiography after acute anterior myocardial infarction and a coronary stent was placed. Abciximab was added to the therapy because of stent thrombosis. Bilateral subconjunctival hemorrhage was observed after the administration of the abciximab treatment. We treated our patient by stopping abciximab and administering artificial tears. CONCLUSİON: For the first time in the literature, we presented the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab, which was managed conservatively.
format Online
Article
Text
id pubmed-9721233
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Associação Paulista de Medicina - APM
record_format MEDLINE/PubMed
spelling pubmed-97212332022-12-06 Bilateral subconjunctival hemorrhage secondary to abciximab use: case report Kul, Selim Sayın, Muhammet Raşit Sao Paulo Med J Case Report CONTEXT: There are no reports on cases of subconjunctival hemorrhage due to use of glycoprotein IIb/IIIa inhibitors. In this report, we present the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab. CASE REPORT: A 40-year-old male patient underwent coronary angiography after acute anterior myocardial infarction and a coronary stent was placed. Abciximab was added to the therapy because of stent thrombosis. Bilateral subconjunctival hemorrhage was observed after the administration of the abciximab treatment. We treated our patient by stopping abciximab and administering artificial tears. CONCLUSİON: For the first time in the literature, we presented the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab, which was managed conservatively. Associação Paulista de Medicina - APM 2017-12-18 /pmc/articles/PMC9721233/ /pubmed/29267537 http://dx.doi.org/10.1590/1516-3180.2017.0182150717 Text en © 2022 by Associação Paulista de Medicina https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons license.
spellingShingle Case Report
Kul, Selim
Sayın, Muhammet Raşit
Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
title Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
title_full Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
title_fullStr Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
title_full_unstemmed Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
title_short Bilateral subconjunctival hemorrhage secondary to abciximab use: case report
title_sort bilateral subconjunctival hemorrhage secondary to abciximab use: case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721233/
https://www.ncbi.nlm.nih.gov/pubmed/29267537
http://dx.doi.org/10.1590/1516-3180.2017.0182150717
work_keys_str_mv AT kulselim bilateralsubconjunctivalhemorrhagesecondarytoabciximabusecasereport
AT sayınmuhammetrasit bilateralsubconjunctivalhemorrhagesecondarytoabciximabusecasereport